Table 1. Inclusion and exclusion criteria.
Inclusion criteria |
· Interventional studies only (either RCT or observational) |
· Sufficient reporting detail of all relevant variables including magnesium dose, form, and time length of administration |
· Standardized instruments to measure anxiety or sleep outcomes (or polysomnography in the case of sleep disorders) |
· Human studies only (all animal studies were excluded) |
· Inclusion not restricted by age of participant or type of magnesium salt |
Exclusion criteria |
· Insufficient dose of magnesium, defined as ≤50 mg/12.5% of RDA for purposes of this review or unknown magnesium dose |
· Presence of >3 other potentially active compounds in the formulation |
· Manuscript language other than English |